English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

An action plan for pan-European defence against new SARS-CoV-2 variants

MPS-Authors
/persons/resource/persons173619

Priesemann,  Viola
Max Planck Research Group Neural Systems Theory, Max Planck Institute for Dynamics and Self-Organization, Max Planck Society;

External Ressource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Priesemann, V., Balling, R., Brinkmann, M. M., Ciesek, S., Czypionka, T., Eckerle, I., et al. (2021). An action plan for pan-European defence against new SARS-CoV-2 variants. The Lancet, 397, 469-470. doi:10.1016/S0140-6736(21)00150-1.


Cite as: http://hdl.handle.net/21.11116/0000-0007-D587-0
Abstract
COVID-19 cases are very high across Europe. Current measures are not reducing virus spread sufficiently, and new SARS-CoV-2 variants are emerging. The B.1.1.7 and B1.351 variants, first identified in the UK and South Africa, respectively, have spread to many European countries.1–5 Although the biological properties of these variants are yet to be characterised, epidemiological data suggest they have a higher transmissibility than the original variant.6,7 These viral properties could increase the effective reproduction number R in the population. In the case of B.1.1.7, estimates suggest R could increase from 1 to about 1.4 with no change in population behavior.3,4 If true, many countries that have succeeded in reducing R to 1 or less will be confronted with a novel wave of viral spread despite the current measures.8,9 Once a more contagious variant has established itself, stabilising the number of new infections will become increasingly difficult.